Moreover, deregulation of PML bodies leads to the activation of PPARδ mediated fatty acid oxidation pathways, which help in cancer stem cell maintenance, leading to disease progression and therapeutic refractoriness [29,30]. The gene discussed is PML; the disease is cancer.